Couple-based lifestyle intervention to prevent type 2 diabetes: protocol for a randomised pilot trial

Author:

Whitaker MadelynORCID,Aguirre Monique C,Gutierrez Chavez Manuel,Beaulieu Elizabeth,Arones Yeny B,Gershenoff Dana,Hinton Kristie,Klein Natalie,Munezerou Uwizeye Jeanne,Napia Eru,Ramos Carmen,Tavake-Pasi O Fahina,Villalta Jeannette,Wolfsfeld Cathy,Witte Brieanne,Maxfield Ellen,Raphael Kalani,Simmons Debra L,Clark Lauren,Sher Tamara,Smith Timothy W,Baucom Katherine JW

Abstract

IntroductionType 2 diabetes is prevalent among US adults. Lifestyle interventions that modify health behaviours prevent or delay progression to diabetes among individuals at high risk. Despite the well-documented influence of individuals’ social context on their health, evidence-based type 2 diabetes prevention interventions do not systematically incorporate participants’ romantic partners. Involving partners of individuals at high risk for type 2 diabetes in primary prevention may improve engagement and outcomes of programmes. The randomised pilot trial protocol described in this manuscript will evaluate a couple-based lifestyle intervention to prevent type 2 diabetes. The objective of the trial is to describe the feasibility of the couple-based intervention and the study protocol to guide planning of a definitive randomised clinical trial (RCT).Methods and analysisWe used community-based participatory research principles to adapt an individual diabetes prevention curriculum for delivery to couples. This parallel two-arm pilot study will include 12 romantic couples in which at least one partner (ie, ‘target individual’) is at risk for type 2 diabetes. Couples will be randomised to either the 2021 version of the CDC’s PreventT2 curriculum designed for delivery to individuals (six couples), or PreventT2 Together, the adapted couple-based curriculum (six couples). Participants and interventionists will be unblinded, but research nurses collecting data will be blinded to treatment allocation. Feasibility of the couple-based intervention and the study protocol will be assessed using both quantitative and qualitative measures.Ethics and disseminationThis study has been approved by the University of Utah IRB (#143079). Findings will be shared with researchers through publications and presentations. We will collaborate with community partners to determine the optimal strategy for communicating findings to community members. Results will inform a subsequent definitive RCT.Trial registration numberNCT05695170

Funder

National Institutes of Health

Publisher

BMJ

Subject

General Medicine

Reference72 articles.

1. Impact of diabetes on cardiovascular disease: an update;Matheus AS de;Int J Hypertens,2013

2. Diabetes and cancer

3. National Center for Health Statistics . Leading causes of death. Cent Dis Control Prev 2019. Available: https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm

4. Centers for Disease Control and Prevention . National diabetes statistics report. US Dep Health Hum Serv 2022. Available: https://www.cdc.gov/diabetes/data/statistics-report/index.html

5. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3